Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Healing of severe esophagitis linked to improvement in peristaltic dysfunction

Feb. 25, 1999

Axcan and Labopharm to develop controlled-release trimebutine formulation

Feb. 25, 1999

Ribozyme issued U.S. patent for ribozyme HCV therapeutics

Feb. 23, 1999

Janssen patents structurally distinct gastric prokinetic agents

Feb. 22, 1999

Polyol anti-Helicobacter pylori agents, compositions and use claimed by Takeda

Feb. 22, 1999

Salix negotiates lafutidine license agreement with Fujirebio

Feb. 18, 1999

Allelix clones GLP-2 receptor; advances development of ALX-0600

Feb. 18, 1999

AxyS initiates phase Ib studies of APC-2059 in acute IBD

Feb. 16, 1999

New synthetic hepatoprotectant under study in India

Feb. 15, 1999

Bristol-Myers Squibb suspends clinical studies of lobucavir

Feb. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...